| Name | Title | Contact Details |
|---|
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
Sonus USA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Terumo Cardiovascular Systems' product line in perfusion circuits is not only one of the most comprehensive in the industry, but also offers an increasing array of products focused on helping surgical teams improve outcomes associated with
Marin General Hospital provides primary and secondary levels of care in addition to Marin Cancer Institute and Haynes Cardiovascular Institute.
Founded in 1961, APDA is the nations largest grassroots network dedicated to assist the more than 1 million Americans living with Parkinson’s disease.